Resultats de la cerca - Edwin P. Alyea

Refinar resultats
  1. 1
    Important Drug Interactions in Hematopoietic Stem Cell Transplantation: What Every Physician Should Know

    Important Drug Interactions in Hematopoietic Stem Cell Transplantation: What Every Physician Should Know per Brett Glotzbecker, Christine Duncan, Edwin P. Alyea, Bonnie Campbell, Robert J. Soiffer

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation

    Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation per Claudia I. Chapuy, Richard M. Kaufman, Edwin P. Alyea, Jean M. Connors

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation

    Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation per Ali G. Saad, Edwin P. Alyea, Patrick Y. Wen, Umberto DeGirolami, Santosh Kesari

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation

    Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation per Vincent T. Ho, Edie Weller, Stephanie J. Lee, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation

    Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation per Corey Cutler, Shuli Li, Vincent T. Ho, John Koreth, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia

    Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia per David D. Berg, Muthiah Vaduganathan, Matthew S. Davids, Edwin P. Alyea, Matthew Torre, Robert F. Padera, Anju Nohria

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy

    Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy per Akiko Saito, David Zahrieh, Corey Cutler, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer, Edwin P. Alyea, S J Lee

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

    Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation per Philippe Armand, Haesook T. Kim, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.

    Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. per Emmanuel Claret, Edwin P. Alyea, Enrica Orsini, Christopher Pickett, Heather Collins, Y Wang, Donna Neuberg, Robert J. Soiffer, Jerome Ritz

    Publicat 1997
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Outcome and Prognostic Factors for Patients Who Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

    Outcome and Prognostic Factors for Patients Who Relapse after Allogeneic Hematopoietic Stem Cell Transplantation per Gita Thanarajasingam, Haesook T. Kim, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer, Philippe Armand

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

    Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Inte... per Vincent T. Ho, Julie Aldridge, Haesook T. Kim, Corey Cutler, John Koreth, Philippe Armand, Joseph H. Antin, Robert J. Soiffer, Edwin P. Alyea

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

    Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell tra... per Francisco M. Marty, Stephanie J. Lee, Michelle M. Fahey, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin, Lindsey R. Baden

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens

    Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens per Akiko Saito, Corey Cutler, David Zahrieh, Robert J. Soiffer, Vincent T. Ho, Edwin P. Alyea, John Koreth, Joseph H. Antin, Stephanie J. Lee

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Toxicity and Efficacy of Defined Doses of CD4+ Donor Lymphocytes for Treatment of Relapse After Allogeneic Bone Marrow Transplant

    Toxicity and Efficacy of Defined Doses of CD4+ Donor Lymphocytes for Treatment of Relapse After Allogeneic Bone Marrow Transplant per Edwin P. Alyea, Robert J. Soiffer, Christine Canning, Donna Neuberg, Robert Schlossman, Christopher Pickett, Heather Collins, Yulan Wang, Kenneth C. Anderson, Jerome Ritz

    Publicat 1998
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation

    Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation per Emmanuel Zorn, Mehrdad Mohseni, Haesook Kim, Fabrice Porcheray, Allison M. Lynch, Roberto Bellucci, Christine Canning, Edwin P. Alyea, Robert J. Soiffer, Jerome Ritz

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age

    Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: Hematologic Malignancy Outcomes Are Not Impaired in Advanced Age per John Koreth, Julie Aldridge, Haesook T. Kim, Edwin P. Alyea, Corey Cutler, Philippe Armand, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer, Vincent T. Ho

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Emergence of a Clinical Daptomycin-Resistant <i>Staphylococcus aureus</i> Isolate during Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia and Osteomyelitis

    Emergence of a Clinical Daptomycin-Resistant <i>Staphylococcus aureus</i> Isolate during Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia and Osteomyeliti... per Francisco M. Marty, Wendy W. Yeh, Christine Wennersten, Lata Venkataraman, Esperanza Albano, Edwin P. Alyea, Howard S. Gold, Lindsey R. Baden, Satish K. Pillai

    Publicat 2006
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Impact of Conditioning Regimen Intensity on Outcome of Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Myelogenous Leukemia and Myelodysplastic Syndrome

    Impact of Conditioning Regimen Intensity on Outcome of Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Myelogenous Leukemia and Myelodysplastic Syndrome per Edwin P. Alyea, Haesook T. Kim, Vincent T. Ho, Corey Cutler, Daniel J. DeAngelo, Richard M. Stone, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    The Impact of Geographic Proximity to Transplant Center on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation

    The Impact of Geographic Proximity to Transplant Center on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation per Karim Abou-Nassar, Haesook T. Kim, Jeff Blossom, Vincent T. Ho, Robert J. Soiffer, Corey Cutler, Edwin P. Alyea, John Koreth, Joseph H. Antin, Philippe Armand

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome

    Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome per Haesook T. Kim, Philippe Armand, David Frederick, Emily Andler, Corey Cutler, John Koreth, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, Vincent T. Ho

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: